common FR940104-2-00078 5 164 211 253 350 369
stock FR940104-2-00078 6 165 212 254 267 351 370
on FR940104-2-00078 9 166 213 226 268 294 371 404 473 501
the FR940104-2-00078 45 167 185 188 191 198 205 210 223 227 234 238 252 258 261 266 269 275 279 284 295 314 318 323 326 342 357 366 372 383 388 413 416 437 445 448 461 464 469 474 485 488 494 502 506 510
national FR940104-2-00078 1 168
association FR940104-2-00078 1 169
of FR940104-2-00078 11 170 190 197 209 241 333 390 415 447 466 512
securities FR940104-2-00078 2 171 417
dealers FR940104-2-00078 1 172
automated FR940104-2-00078 1 173
quotations/national FR940104-2-00078 1 174
market FR940104-2-00078 3 175 364 513
system FR940104-2-00078 5 176 240 281 320 374
( FR940104-2-00078 5 177 231 272 311 354
`` FR940104-2-00078 1 178
nasdaq/nms FR940104-2-00078 6 179 214 239 280 319 373
'' FR940104-2-00078 1 180
) FR940104-2-00078 5 181 233 274 313 356
. FR940104-2-00078 7 182 398 468 504 520 526 530
according FR940104-2-00078 1 183
to FR940104-2-00078 9 184 219 265 328 378 412 477 497 517
company FR940104-2-00078 9 186 235 276 285 315 327 358 367 384
, FR940104-2-00078 21 187 200 336 340 385 403 407 408 421 425 427 429 432 453 456 471 479 492 508 515 524
decision FR940104-2-00078 1 189
board FR940104-2-00078 1 192
followed FR940104-2-00078 1 193
a FR940104-2-00078 3 194 363 499
lengthy FR940104-2-00078 1 195
study FR940104-2-00078 1 196
matter FR940104-2-00078 2 199 503
and FR940104-2-00078 8 201 249 297 335 353 395 418 450
was FR940104-2-00078 1 202
based FR940104-2-00078 2 203 472
upon FR940104-2-00078 2 204 435
belief FR940104-2-00078 1 206
that FR940104-2-00078 5 207 237 278 317 360
listing FR940104-2-00078 2 208 225
will FR940104-2-00078 6 215 244 282 321 375 480
be FR940104-2-00078 3 216 376 458
more FR940104-2-00078 2 217 288
beneficial FR940104-2-00078 1 218
its FR940104-2-00078 3 220 330 349
stockholders FR940104-2-00078 2 221 287
than FR940104-2-00078 3 222 255 290
present FR940104-2-00078 1 224
amex FR940104-2-00078 3 228 270 296
because FR940104-2-00078 1 229
: FR940104-2-00078 1 230
1 FR940104-2-00078 1 232
believes FR940104-2-00078 4 236 277 316 359
competing FR940104-2-00078 1 242
marketmakers FR940104-2-00078 2 243 334
result FR940104-2-00078 1 245
in FR940104-2-00078 6 246 300 337 348 365 442
increased FR940104-2-00078 1 247
visibility FR940104-2-00078 1 248
sponsorship FR940104-2-00078 1 250
for FR940104-2-00078 5 251 325 346 463 505
is FR940104-2-00078 3 256 291 308
presently FR940104-2-00078 2 257 292
case FR940104-2-00078 1 259
with FR940104-2-00078 2 260 444
single FR940104-2-00078 1 262
specialist FR940104-2-00078 1 263
assigned FR940104-2-00078 1 264
; FR940104-2-00078 4 271 310 352 534
2 FR940104-2-00078 1 273
offer FR940104-2-00078 2 283 322
's FR940104-2-00078 2 286 368
liquidity FR940104-2-00078 1 289
available FR940104-2-00078 2 293 345
less FR940104-2-00078 1 298
volatility FR940104-2-00078 1 299
quoted FR940104-2-00078 1 301
prices FR940104-2-00078 1 302
per FR940104-2-00078 1 303
share FR940104-2-00078 1 304
when FR940104-2-00078 1 305
trading FR940104-2-00078 2 306 347
volume FR940104-2-00078 1 307
slight FR940104-2-00078 1 309
3 FR940104-2-00078 1 312
opportunity FR940104-2-00078 1 324
secure FR940104-2-00078 1 329
own FR940104-2-00078 1 331
group FR940104-2-00078 1 332
doing FR940104-2-00078 1 338
so FR940104-2-00078 1 339
expand FR940104-2-00078 1 341
capital FR940104-2-00078 1 343
base FR940104-2-00078 1 344
4 FR940104-2-00078 1 355
firms FR940104-2-00078 2 361 391
making FR940104-2-00078 1 362
inclined FR940104-2-00078 1 377
issue FR940104-2-00078 2 379 481
research FR940104-2-00078 2 380 394
reports FR940104-2-00078 2 381 397
concerning FR940104-2-00078 1 382
thereby FR940104-2-00078 1 386
increasing FR940104-2-00078 1 387
number FR940104-2-00078 1 389
providing FR940104-2-00078 1 392
institutional FR940104-2-00078 1 393
advisory FR940104-2-00078 1 396
any FR940104-2-00078 2 399 455
interested FR940104-2-00078 1 400
person FR940104-2-00078 1 401
may FR940104-2-00078 1 402
or FR940104-2-00078 1 405
before FR940104-2-00078 1 406
submit FR940104-2-00078 1 409
by FR940104-2-00078 3 410 460 509
letter FR940104-2-00078 1 411
secretary FR940104-2-00078 2 414 525
exchange FR940104-2-00078 1 419
commission FR940104-2-00078 5 420 462 470 495 507
450 FR940104-2-00078 1 422
fifth FR940104-2-00078 1 423
street FR940104-2-00078 1 424
nw. FR940104-2-00078 1 426
washington FR940104-2-00078 1 428
dc FR940104-2-00078 1 430
20549 FR940104-2-00078 1 431
facts FR940104-2-00078 1 433
bearing FR940104-2-00078 1 434
whether FR940104-2-00078 1 436
application FR940104-2-00078 2 438 486
has FR940104-2-00078 1 439
been FR940104-2-00078 1 440
made FR940104-2-00078 1 441
accordance FR940104-2-00078 1 443
rules FR940104-2-00078 1 446
exchanges FR940104-2-00078 1 449
what FR940104-2-00078 1 451
terms FR940104-2-00078 1 452
if FR940104-2-00078 1 454
should FR940104-2-00078 1 457
imposed FR940104-2-00078 1 459
protection FR940104-2-00078 1 465
investors FR940104-2-00078 1 467
information FR940104-2-00078 1 475
submitted FR940104-2-00078 1 476
it FR940104-2-00078 1 478
an FR940104-2-00078 1 482
order FR940104-2-00078 2 483 498
granting FR940104-2-00078 1 484
after FR940104-2-00078 1 487
date FR940104-2-00078 1 489
mentioned FR940104-2-00078 1 490
above FR940104-2-00078 1 491
unless FR940104-2-00078 1 493
determines FR940104-2-00078 1 496
hearing FR940104-2-00078 1 500
division FR940104-2-00078 1 511
regulation FR940104-2-00078 1 514
pursuant FR940104-2-00078 1 516
delegated FR940104-2-00078 1 518
authority FR940104-2-00078 1 519
jonathan FR940104-2-00078 1 521
g. FR940104-2-00078 1 522
katz FR940104-2-00078 1 523
[ FR940104-2-00078 1 527
fr FR940104-2-00078 1 528
doc FR940104-2-00078 1 529
9450 FR940104-2-00078 1 531
filed FR940104-2-00078 1 532
1394 FR940104-2-00078 1 533
8:45 FR940104-2-00078 1 535
am FR940104-2-00078 1 536
] FR940104-2-00078 1 537
billing FR940104-2-00078 1 538
code FR940104-2-00078 1 539
801001m FR940104-2-00078 1 540
tennessee FR940104-2-00079 5 0 32 56 155 192
valley FR940104-2-00079 5 1 33 57 156 193
authority FR940104-2-00079 5 2 34 58 157 194
paperwork FR940104-2-00079 2 3 79
reduction FR940104-2-00079 2 4 80
act FR940104-2-00079 2 5 81
of FR940104-2-00079 17 6 23 45 72 77 82 104 160 167 215 222 232 239 265 292 340 359
1980 FR940104-2-00079 2 7 83
, FR940104-2-00079 19 8 90 101 112 123 125 158 165 171 173 191 195 203 205 366 368 370 379 382
as FR940104-2-00079 2 9 91
amended FR940104-2-00079 2 10 92
by FR940104-2-00079 4 11 20 42 93
public FR940104-2-00079 4 12 94 241 300
law FR940104-2-00079 2 13 95
99591 FR940104-2-00079 2 14 96
; FR940104-2-00079 4 15 176 208 393
information FR940104-2-00079 9 16 38 73 100 106 161 223 293 348
collection FR940104-2-00079 4 17 71 107 224
under FR940104-2-00079 4 18 40 74 312
review FR940104-2-00079 2 19 41
the FR940104-2-00079 16 21 43 55 66 70 75 78 105 117 143 150 154 299 347 351 357
office FR940104-2-00079 4 22 44 159 166
management FR940104-2-00079 5 24 46 168 229 362
and FR940104-2-00079 9 25 47 109 126 147 162 169 290 372
budget FR940104-2-00079 4 26 48 170 256
( FR940104-2-00079 7 27 49 59 84 179 199 209
omb FR940104-2-00079 3 28 50 65
) FR940104-2-00079 7 29 51 61 89 181 202 211
agency FR940104-2-00079 4 30 118 144 184
: FR940104-2-00079 15 31 37 54 178 187 217 225 234 242 252 260 268 276 285 294
. FR940104-2-00079 19 35 52 97 131 183 213 220 230 237 246 254 262 270 278 287 346 375 385 389
action FR940104-2-00079 1 36
collections FR940104-2-00079 1 39
summary FR940104-2-00079 1 53
tva FR940104-2-00079 4 60 226 295 310
has FR940104-2-00079 1 62
sent FR940104-2-00079 1 63
to FR940104-2-00079 5 64 116 142 149 297
following FR940104-2-00079 1 67
proposal FR940104-2-00079 1 68
for FR940104-2-00079 7 69 99 153 289 304 329 364
provisions FR940104-2-00079 1 76
44 FR940104-2-00079 1 85
usc FR940104-2-00079 1 86
chapter FR940104-2-00079 1 87
35 FR940104-2-00079 1 88
requests FR940104-2-00079 1 98
including FR940104-2-00079 1 102
copies FR940104-2-00079 1 103
proposed FR940104-2-00079 2 108 323
supporting FR940104-2-00079 1 110
documentation FR940104-2-00079 1 111
should FR940104-2-00079 2 113 135
be FR940104-2-00079 3 114 136 354
directed FR940104-2-00079 1 115
clearance FR940104-2-00079 3 119 145 185
officer FR940104-2-00079 4 120 146 152 186
whose FR940104-2-00079 1 121
name FR940104-2-00079 1 122
address FR940104-2-00079 1 124
telephone FR940104-2-00079 2 127 177
number FR940104-2-00079 2 128 264
appear FR940104-2-00079 1 129
below FR940104-2-00079 1 130
questions FR940104-2-00079 1 132
or FR940104-2-00079 3 133 244 249
comments FR940104-2-00079 1 134
made FR940104-2-00079 1 137
within FR940104-2-00079 1 138
30 FR940104-2-00079 1 139
days FR940104-2-00079 1 140
directly FR940104-2-00079 1 141
also FR940104-2-00079 1 148
desk FR940104-2-00079 1 151
regulatory FR940104-2-00079 1 163
affairs FR940104-2-00079 1 164
washington FR940104-2-00079 1 172
dc FR940104-2-00079 1 174
20503 FR940104-2-00079 1 175
202 FR940104-2-00079 1 180
3953084 FR940104-2-00079 1 182
mark FR940104-2-00079 1 188
r. FR940104-2-00079 1 189
winter FR940104-2-00079 1 190
1101 FR940104-2-00079 1 196
market FR940104-2-00079 1 197
street FR940104-2-00079 1 198
br FR940104-2-00079 1 200
6b FR940104-2-00079 1 201
chattanooga FR940104-2-00079 1 204
tn FR940104-2-00079 1 206
374022801 FR940104-2-00079 1 207
615 FR940104-2-00079 1 210
7512523 FR940104-2-00079 1 212
type FR940104-2-00079 2 214 238
request FR940104-2-00079 1 216
regular FR940104-2-00079 1 218
submission FR940104-2-00079 1 219
title FR940104-2-00079 1 221
aquatic FR940104-2-00079 3 227 306 360
plant FR940104-2-00079 2 228 361
frequency FR940104-2-00079 1 231
use FR940104-2-00079 2 233 291
on FR940104-2-00079 1 235
occasion FR940104-2-00079 1 236
affected FR940104-2-00079 2 240 251
individuals FR940104-2-00079 1 243
households FR940104-2-00079 1 245
small FR940104-2-00079 1 247
businesses FR940104-2-00079 1 248
organization FR940104-2-00079 1 250
no FR940104-2-00079 1 253
federal FR940104-2-00079 1 255
functional FR940104-2-00079 1 257
category FR940104-2-00079 1 258
code FR940104-2-00079 2 259 398
452 FR940104-2-00079 1 261
estimated FR940104-2-00079 3 263 271 279
annual FR940104-2-00079 2 266 273
responses FR940104-2-00079 1 267
2000 FR940104-2-00079 1 269
total FR940104-2-00079 1 272
burden FR940104-2-00079 2 274 281
hours FR940104-2-00079 2 275 282
400 FR940104-2-00079 1 277
average FR940104-2-00079 1 280
per FR940104-2-00079 1 283
response FR940104-2-00079 1 284
.2 FR940104-2-00079 1 286
need FR940104-2-00079 1 288
committed FR940104-2-00079 1 296
involving FR940104-2-00079 1 298
in FR940104-2-00079 3 301 308 319
developing FR940104-2-00079 1 302
plans FR940104-2-00079 2 303 363
managing FR940104-2-00079 1 305
plants FR940104-2-00079 1 307
individual FR940104-2-00079 1 309
lakes FR940104-2-00079 2 311 374
a FR940104-2-00079 3 313 327 337
supplemental FR940104-2-00079 1 314
environmental FR940104-2-00079 1 315
impact FR940104-2-00079 1 316
statement FR940104-2-00079 1 317
completed FR940104-2-00079 1 318
august FR940104-2-00079 1 320
1993. FR940104-2-00079 1 321
this FR940104-2-00079 2 322 333
survey FR940104-2-00079 2 324 352
will FR940104-2-00079 2 325 353
provide FR940104-2-00079 1 326
mechanism FR940104-2-00079 1 328
obtaining FR940104-2-00079 1 330
input FR940104-2-00079 1 331
into FR940104-2-00079 2 332 356
planning FR940104-2-00079 1 334
process FR940104-2-00079 1 335
from FR940104-2-00079 2 336 350
representative FR940104-2-00079 1 338
sample FR940104-2-00079 1 339
people FR940104-2-00079 1 341
living FR940104-2-00079 1 342
near FR940104-2-00079 1 343
each FR940104-2-00079 1 344
lake FR940104-2-00079 1 345
obtained FR940104-2-00079 1 349
factored FR940104-2-00079 1 355
development FR940104-2-00079 1 358
chickamauga FR940104-2-00079 1 365
kentucky FR940104-2-00079 1 367
wheeler FR940104-2-00079 1 369
nickajack FR940104-2-00079 1 371
guntersville FR940104-2-00079 1 373
john FR940104-2-00079 1 376
j. FR940104-2-00079 1 377
o'donnell FR940104-2-00079 1 378
vice FR940104-2-00079 1 380
president FR940104-2-00079 1 381
facilities FR940104-2-00079 1 383
services FR940104-2-00079 1 384
[ FR940104-2-00079 1 386
fr FR940104-2-00079 1 387
doc FR940104-2-00079 1 388
9412 FR940104-2-00079 1 390
filed FR940104-2-00079 1 391
1394 FR940104-2-00079 1 392
8:45 FR940104-2-00079 1 394
am FR940104-2-00079 1 395
] FR940104-2-00079 1 396
billing FR940104-2-00079 1 397
812008m FR940104-2-00079 1 399
department FR940104-2-00080 4 0 15 32 210
of FR940104-2-00080 38 1 16 33 45 58 66 78 180 211 236 241 268 288 294 344 351 366 378 399 413 460 477 488 519 531 539 577 590 601 623 645 651 689 701 740 775 781 955
veterans FR940104-2-00080 7 2 17 34 46 206 212 733
affairs FR940104-2-00080 5 3 18 35 47 213
disease FR940104-2-00080 7 4 302 367 409 497 510 784
not FR940104-2-00080 8 5 85 175 523 552 614 634 950
associated FR940104-2-00080 2 6 306
with FR940104-2-00080 4 7 264 307 717
exposure FR940104-2-00080 11 8 71 282 309 337 405 459 640 768 831 865
to FR940104-2-00080 16 9 72 259 273 283 304 317 355 371 447 462 563 598 769 822 847
certain FR940104-2-00080 1 10
herbicide FR940104-2-00080 8 11 336 404 464 473 639 830 864
agents FR940104-2-00080 1 12
agency FR940104-2-00080 1 13
: FR940104-2-00080 7 14 21 25 91 190 233 737
. FR940104-2-00080 16 19 23 185 230 250 310 410 511 546 584 649 695 789 806 836 960
action FR940104-2-00080 1 20
notice FR940104-2-00080 4 22 41 530 844
summary FR940104-2-00080 1 24
as FR940104-2-00080 1 26
required FR940104-2-00080 1 27
by FR940104-2-00080 2 28 53
law FR940104-2-00080 5 29 245 415 549 849
, FR940104-2-00080 84 30 48 60 94 97 100 103 107 110 113 115 121 126 129 134 138 141 150 153 156 159 162 165 193 195 197 200 205 209 214 218 220 222 225 243 247 255 316 321 338 423 431 438 468 498 525 534 557 574 579 656 659 664 666 675 715 720 725 730 746 750 799 845 851 869 872 875 878 882 885 888 890 896 901 904 909 913 916 925 928 931 934 937 940
the FR940104-2-00080 56 31 43 50 54 76 81 88 172 237 257 265 275 279 292 297 318 332 342 345 349 352 357 363 376 381 407 420 439 443 450 454 478 486 491 499 513 540 561 569 588 599 621 642 646 677 686 690 752 773 778 795 807 815 819 853 947
( FR940104-2-00080 12 36 144 226 252 270 322 360 386 436 466 800 919
va FR940104-2-00080 2 37 812
) FR940104-2-00080 12 38 149 228 254 272 324 362 388 456 494 805 924
hereby FR940104-2-00080 1 39
gives FR940104-2-00080 1 40
that FR940104-2-00080 16 42 63 313 418 432 509 516 532 544 629 755 758 762 811 837 857
secretary FR940104-2-00080 12 44 173 258 421 500 514 562 678 753 808 854 948
under FR940104-2-00080 1 49
authority FR940104-2-00080 1 51
granted FR940104-2-00080 1 52
agent FR940104-2-00080 4 55 238 465 735
orange FR940104-2-00080 3 56 239 736
act FR940104-2-00080 2 57 240
1991 FR940104-2-00080 3 59 242 253
has FR940104-2-00080 5 61 174 679 839 949
determined FR940104-2-00080 3 62 177 952
a FR940104-2-00080 20 64 178 328 392 400 433 469 496 517 529 594 605 610 615 627 635 728 763 825 953
presumption FR940104-2-00080 4 65 179 518 954
service FR940104-2-00080 7 67 181 204 374 506 520 956
connection FR940104-2-00080 5 68 182 507 521 957
based FR940104-2-00080 2 69 424
on FR940104-2-00080 4 70 425 747 798
herbicides FR940104-2-00080 5 73 284 372 741 770
used FR940104-2-00080 6 74 285 354 474 742 771
in FR940104-2-00080 13 75 286 291 375 471 475 485 653 684 743 772 794 818
republic FR940104-2-00080 5 77 293 377 487 774
vietnam FR940104-2-00080 10 79 82 295 298 379 382 489 492 744 776
during FR940104-2-00080 5 80 296 373 380 490
era FR940104-2-00080 4 83 299 383 493
is FR940104-2-00080 11 84 183 327 391 445 522 613 631 633 859 958
warranted FR940104-2-00080 4 86 184 524 959
for FR940104-2-00080 11 87 170 186 442 508 543 609 618 661 712 945
following FR940104-2-00080 1 89
conditions FR940104-2-00080 2 90 835
prostate FR940104-2-00080 2 92 867
cancer FR940104-2-00080 12 93 112 148 152 155 161 868 887 923 927 930 936
peripheral FR940104-2-00080 2 95 870
neuropathy FR940104-2-00080 2 96 871
hepatobiliary FR940104-2-00080 2 98 873
cancers FR940104-2-00080 8 99 102 106 109 874 877 881 884
bone FR940104-2-00080 2 101 876
female FR940104-2-00080 2 104 879
reproductive FR940104-2-00080 2 105 880
renal FR940104-2-00080 2 108 883
testicular FR940104-2-00080 2 111 886
leukemia FR940104-2-00080 2 114 889
abnormal FR940104-2-00080 2 116 891
sperm FR940104-2-00080 2 117 892
parameters FR940104-2-00080 2 118 893
and FR940104-2-00080 28 119 123 131 166 202 300 335 348 385 406 428 481 495 580 641 676 706 721 734 777 785 832 842 866 894 898 906 941
infertility FR940104-2-00080 2 120 895
cognitive FR940104-2-00080 2 122 897
neuropsychiatric FR940104-2-00080 2 124 899
disorders FR940104-2-00080 10 125 133 137 140 143 900 908 912 915 918
motor/coordination FR940104-2-00080 2 127 902
dysfunction FR940104-2-00080 2 128 903
metabolic FR940104-2-00080 2 130 905
digestive FR940104-2-00080 2 132 907
immune FR940104-2-00080 2 135 910
system FR940104-2-00080 2 136 911
circulatory FR940104-2-00080 2 139 914
respiratory FR940104-2-00080 2 142 917
other FR940104-2-00080 6 145 168 397 834 920 943
than FR940104-2-00080 3 146 673 921
lung FR940104-2-00080 2 147 922
nasal/nasopharyngeal FR940104-2-00080 2 151 926
skin FR940104-2-00080 2 154 929
gastrointestinal FR940104-2-00080 2 157 932
tumors FR940104-2-00080 4 158 164 933 939
bladder FR940104-2-00080 2 160 935
brain FR940104-2-00080 2 163 938
any FR940104-2-00080 3 167 833 942
condition FR940104-2-00080 4 169 612 648 944
which FR940104-2-00080 5 171 535 592 603 946
specifically FR940104-2-00080 2 176 951
further FR940104-2-00080 1 187
information FR940104-2-00080 2 188 232
contact FR940104-2-00080 1 189
john FR940104-2-00080 1 191
bisset FR940104-2-00080 1 192
jr. FR940104-2-00080 1 194
consultant FR940104-2-00080 1 196
regulations FR940104-2-00080 3 198 503 791
staff FR940104-2-00080 1 199
compensation FR940104-2-00080 1 201
pension FR940104-2-00080 1 203
benefits FR940104-2-00080 1 207
administration FR940104-2-00080 1 208
810 FR940104-2-00080 1 215
vermont FR940104-2-00080 1 216
avenue FR940104-2-00080 1 217
nw. FR940104-2-00080 1 219
washington FR940104-2-00080 1 221
dc FR940104-2-00080 1 223
20420 FR940104-2-00080 1 224
202 FR940104-2-00080 1 227
2333005 FR940104-2-00080 1 229
supplementary FR940104-2-00080 1 231
section FR940104-2-00080 2 234 411
3 FR940104-2-00080 2 235 387
public FR940104-2-00080 5 244 414 548 723 848
1024 FR940104-2-00080 4 246 416 550 850
105 FR940104-2-00080 1 248
stat FR940104-2-00080 1 249
11 FR940104-2-00080 1 251
directed FR940104-2-00080 1 256
enter FR940104-2-00080 1 260
into FR940104-2-00080 3 261 340 566
an FR940104-2-00080 4 262 463 472 537
agreement FR940104-2-00080 1 263
national FR940104-2-00080 1 266
academy FR940104-2-00080 1 267
sciences FR940104-2-00080 1 269
nas FR940104-2-00080 4 271 314 726 820
review FR940104-2-00080 4 274 583 814 838
scientific FR940104-2-00080 5 276 346 429 541 702
evidence FR940104-2-00080 8 277 347 398 430 441 452 624 691
concerning FR940104-2-00080 2 278 692
association FR940104-2-00080 10 280 330 358 435 444 455 637 765 827 862
between FR940104-2-00080 8 281 331 403 458 638 767 829 863
support FR940104-2-00080 2 287 476
military FR940104-2-00080 2 289 483
operations FR940104-2-00080 2 290 484
each FR940104-2-00080 1 301
suspected FR940104-2-00080 1 303
be FR940104-2-00080 1 305
such FR940104-2-00080 1 308
congress FR940104-2-00080 1 311
mandated FR940104-2-00080 1 312
determine FR940104-2-00080 2 315 823
extent FR940104-2-00080 1 319
possible FR940104-2-00080 1 320
1 FR940104-2-00080 1 323
whether FR940104-2-00080 5 325 389 568 620 824
there FR940104-2-00080 4 326 390 630 858
statistical FR940104-2-00080 2 329 654
suspect FR940104-2-00080 2 333 408
diseases FR940104-2-00080 2 334 694
taking FR940104-2-00080 1 339
account FR940104-2-00080 1 341
strength FR940104-2-00080 1 343
appropriateness FR940104-2-00080 1 350
methods FR940104-2-00080 1 353
detect FR940104-2-00080 1 356
; FR940104-2-00080 2 359 384
2 FR940104-2-00080 2 361 412
increased FR940104-2-00080 1 364
risk FR940104-2-00080 3 365 597 608
among FR940104-2-00080 1 368
individuals FR940104-2-00080 1 369
exposed FR940104-2-00080 1 370
plausible FR940104-2-00080 1 393
biological FR940104-2-00080 1 394
mechanism FR940104-2-00080 1 395
or FR940104-2-00080 4 396 448 632 703
causal FR940104-2-00080 1 401
relationship FR940104-2-00080 1 402
provides FR940104-2-00080 1 417
whenever FR940104-2-00080 1 419
determines FR940104-2-00080 2 422 515
sound FR940104-2-00080 1 426
medical FR940104-2-00080 2 427 704
positive FR940104-2-00080 6 434 595 636 764 826 861
ie FR940104-2-00080 2 437 467
credible FR940104-2-00080 4 440 451 555 672
equal FR940104-2-00080 1 446
outweighs FR940104-2-00080 1 449
against FR940104-2-00080 1 453
exists FR940104-2-00080 3 457 766 828
humans FR940104-2-00080 1 461
chemical FR940104-2-00080 1 470
united FR940104-2-00080 1 479
states FR940104-2-00080 1 480
allied FR940104-2-00080 1 482
will FR940104-2-00080 2 501 527
publish FR940104-2-00080 2 502 528
establishing FR940104-2-00080 1 504
presumptive FR940104-2-00080 1 505
if FR940104-2-00080 1 512
he FR940104-2-00080 2 526 759
determination FR940104-2-00080 3 533 545 856
includes FR940104-2-00080 1 536
explanation FR940104-2-00080 1 538
basis FR940104-2-00080 1 542
although FR940104-2-00080 1 547
does FR940104-2-00080 2 551 559
define FR940104-2-00080 1 553
`` FR940104-2-00080 3 554 564 732
'' FR940104-2-00080 3 556 585 745
it FR940104-2-00080 1 558
instruct FR940104-2-00080 1 560
take FR940104-2-00080 1 565
consideration FR940104-2-00080 1 567
results FR940104-2-00080 1 570
are FR940104-2-00080 3 571 575 669
statistically FR940104-2-00080 1 572
significant FR940104-2-00080 1 573
capable FR940104-2-00080 1 576
replication FR940104-2-00080 1 578
withstand FR940104-2-00080 1 581
peer FR940104-2-00080 1 582
simply FR940104-2-00080 1 586
comparing FR940104-2-00080 1 587
number FR940104-2-00080 2 589 600
studies FR940104-2-00080 4 591 602 668 711
report FR940104-2-00080 4 593 604 729 821
relative FR940104-2-00080 2 596 607
negative FR940104-2-00080 1 606
particular FR940104-2-00080 2 611 647
valid FR940104-2-00080 1 616
method FR940104-2-00080 1 617
determining FR940104-2-00080 1 619
weight FR940104-2-00080 2 622 683
overall FR940104-2-00080 2 625 687
supports FR940104-2-00080 1 626
finding FR940104-2-00080 1 628
subsequent FR940104-2-00080 2 643 779
development FR940104-2-00080 2 644 780
because FR940104-2-00080 1 650
differences FR940104-2-00080 1 652
significance FR940104-2-00080 1 655
confidence FR940104-2-00080 1 657
levels FR940104-2-00080 1 658
control FR940104-2-00080 1 660
confounding FR940104-2-00080 1 662
factors FR940104-2-00080 1 663
etc. FR940104-2-00080 1 665
some FR940104-2-00080 1 667
clearly FR940104-2-00080 1 670
more FR940104-2-00080 2 671 682
others FR940104-2-00080 1 674
given FR940104-2-00080 1 680
them FR940104-2-00080 1 681
evaluating FR940104-2-00080 1 685
credibility FR940104-2-00080 1 688
specific FR940104-2-00080 1 693
after FR940104-2-00080 1 696
reviewing FR940104-2-00080 1 697
approximately FR940104-2-00080 2 698 708
6420 FR940104-2-00080 1 699
abstracts FR940104-2-00080 1 700
articles FR940104-2-00080 1 705
selecting FR940104-2-00080 1 707
230 FR940104-2-00080 1 709
epidemiologic FR940104-2-00080 1 710
detailed FR940104-2-00080 1 713
analysis FR940104-2-00080 1 714
consulting FR940104-2-00080 1 716
outside FR940104-2-00080 1 718
experts FR940104-2-00080 1 719
conducting FR940104-2-00080 1 722
hearings FR940104-2-00080 1 724
issued FR940104-2-00080 1 727
entitled FR940104-2-00080 1 731
health FR940104-2-00080 1 738
effects FR940104-2-00080 1 739
july FR940104-2-00080 1 748
27 FR940104-2-00080 1 749
1993. FR940104-2-00080 1 751
announced FR940104-2-00080 2 754 810
same FR940104-2-00080 1 756
day FR940104-2-00080 1 757
had FR940104-2-00080 1 760
concluded FR940104-2-00080 1 761
hodgkin FR940104-2-00080 1 782
's FR940104-2-00080 2 783 855
porphyria FR940104-2-00080 1 786
cutanea FR940104-2-00080 1 787
tarda FR940104-2-00080 1 788
proposed FR940104-2-00080 1 790
were FR940104-2-00080 1 792
published FR940104-2-00080 1 793
federal FR940104-2-00080 1 796
register FR940104-2-00080 1 797
see FR940104-2-00080 1 801
58 FR940104-2-00080 1 802
fr FR940104-2-00080 1 803
5052830 FR940104-2-00080 1 804
also FR940104-2-00080 1 809
would FR940104-2-00080 1 813
remaining FR940104-2-00080 1 816
findings FR940104-2-00080 1 817
been FR940104-2-00080 1 840
completed FR940104-2-00080 1 841
this FR940104-2-00080 1 843
pursuant FR940104-2-00080 1 846
conveys FR940104-2-00080 1 852
no FR940104-2-00080 1 860
the FR940104-2-00081 16 0 270 352 365 390 395 408 428 510 528 571 584 587 603 613 628
nas FR940104-2-00081 2 1 429
report FR940104-2-00081 2 2 430
assigns FR940104-2-00081 2 3 431
prostate FR940104-2-00081 7 4 57 85 247 341 356 402
cancer FR940104-2-00081 16 5 58 65 86 124 160 222 248 261 272 342 357 403 449 485 490
to FR940104-2-00081 11 6 129 227 376 491 497 523 552 566 601 623
a FR940104-2-00081 9 7 32 60 242 311 421 492 525 606
category FR940104-2-00081 2 8 493
labeled FR940104-2-00081 2 9 494
limited/suggestive FR940104-2-00081 1 10
evidence FR940104-2-00081 7 11 23 39 397 410 496 600
of FR940104-2-00081 12 12 25 137 269 299 314 347 355 514 532 586 631
an FR940104-2-00081 6 13 26 399 413 500 533
association FR940104-2-00081 9 14 27 83 400 414 423 501 534 610
, FR940104-2-00081 85 15 36 44 46 92 95 98 101 104 107 109 111 114 117 120 131 143 146 148 150 153 156 176 179 182 186 188 191 194 197 200 203 206 209 212 215 218 256 259 278 281 286 306 319 321 323 326 329 332 335 389 415 434 437 440 444 447 450 452 458 463 466 471 475 478 487 503 517 519 555 559 561 563 578 581 595 611 620 646 648 654 663 678 681 684
which FR940104-2-00081 5 16 66 80 504 655
it FR940104-2-00081 4 17 372 373 579
defined FR940104-2-00081 2 18 506
as FR940104-2-00081 4 19 507 557 668
meaning FR940104-2-00081 2 20 508
there FR940104-2-00081 3 21 74 597
is FR940104-2-00081 5 22 40 59 368 505
suggestive FR940104-2-00081 1 24
between FR940104-2-00081 4 28 84 401 621
herbicide FR940104-2-00081 6 29 88 362 405 536 553
exposure FR940104-2-00081 8 30 89 363 406 537 554 565 622
and FR940104-2-00081 19 31 47 87 230 251 294 340 404 416 456 460 468 488 548 564 627 658 664 670
particular FR940104-2-00081 1 33
health FR940104-2-00081 2 34 301
outcome FR940104-2-00081 1 35
but FR940104-2-00081 1 37
that FR940104-2-00081 8 38 371 394 420 509 596 618 644
limited FR940104-2-00081 1 41
because FR940104-2-00081 1 42
chance FR940104-2-00081 1 43
bias FR940104-2-00081 1 45
confounding FR940104-2-00081 1 48
could FR940104-2-00081 1 49
not FR940104-2-00081 2 50 425
be FR940104-2-00081 3 51 382 542
ruled FR940104-2-00081 1 52
out FR940104-2-00081 1 53
with FR940104-2-00081 5 54 71 168 361 535
confidence FR940104-2-00081 1 55
. FR940104-2-00081 18 56 73 110 133 149 170 187 232 236 289 297 344 364 387 427 538 570 643
very FR940104-2-00081 1 61
common FR940104-2-00081 2 62 546
male FR940104-2-00081 1 63
genitourinary FR940104-2-00081 1 64
shows FR940104-2-00081 1 67
marked FR940104-2-00081 1 68
increased FR940104-2-00081 2 69 353
prevalence FR940104-2-00081 1 70
age FR940104-2-00081 1 72
are FR940104-2-00081 3 75 513 656
statistically FR940104-2-00081 1 76
significant FR940104-2-00081 3 77 608 662
occupational FR940104-2-00081 3 78 238 665
studies FR940104-2-00081 4 79 239 512 666
show FR940104-2-00081 1 81
no FR940104-2-00081 2 82 660
( FR940104-2-00081 7 90 254 316 481 637 672 675
eg FR940104-2-00081 2 91 255
fingerhut FR940104-2-00081 1 93
ma FR940104-2-00081 1 94
halperin FR940104-2-00081 1 96
we FR940104-2-00081 1 97
marlow FR940104-2-00081 1 99
da FR940104-2-00081 1 100
piacitelli FR940104-2-00081 1 102
la FR940104-2-00081 1 103
honchar FR940104-2-00081 1 105
pa FR940104-2-00081 3 106 116 181
sweeney FR940104-2-00081 1 108
greife FR940104-2-00081 1 112
al FR940104-2-00081 1 113
dill FR940104-2-00081 1 115
steenland FR940104-2-00081 1 118
k. FR940104-2-00081 1 119
suruda FR940104-2-00081 1 121
aj FR940104-2-00081 1 122
1991. FR940104-2-00081 3 123 159 221
mortality FR940104-2-00081 6 125 161 223 262 291 343
in FR940104-2-00081 5 126 164 224 263 615
workers FR940104-2-00081 4 127 163 225 253
exposed FR940104-2-00081 2 128 226
2,3,7 FR940104-2-00081 1 130
,-pdioxin FR940104-2-00081 1 132
new FR940104-2-00081 1 134
england FR940104-2-00081 1 135
journal FR940104-2-00081 3 136 268 346
medicine FR940104-2-00081 1 138
324:212218 FR940104-2-00081 1 139
; FR940104-2-00081 4 140 173 275 304
manz FR940104-2-00081 1 141
a. FR940104-2-00081 1 142
berger FR940104-2-00081 1 144
j. FR940104-2-00081 4 145 214 283 683
dwyer FR940104-2-00081 1 147
fleschjanys FR940104-2-00081 1 151
d. FR940104-2-00081 5 152 190 322 334 337
nagel FR940104-2-00081 1 154
s. FR940104-2-00081 2 155 280
waltsgott FR940104-2-00081 1 157
h. FR940104-2-00081 2 158 318
among FR940104-2-00081 4 162 249 292 358
chemical FR940104-2-00081 1 165
plant FR940104-2-00081 1 166
contaminated FR940104-2-00081 1 167
dioxin FR940104-2-00081 2 169 626
lancet FR940104-2-00081 2 171 233
338:959964 FR940104-2-00081 1 172
saracci FR940104-2-00081 1 174
r. FR940104-2-00081 4 175 220 325 677
kogevinas FR940104-2-00081 1 177
m. FR940104-2-00081 4 178 202 211 680
bertazzi FR940104-2-00081 1 180
bueno FR940104-2-00081 1 183
de FR940104-2-00081 1 184
mesquita FR940104-2-00081 1 185
coggon FR940104-2-00081 1 189
green FR940104-2-00081 1 192
lm FR940104-2-00081 1 193
kauppinen FR940104-2-00081 1 195
t. FR940104-2-00081 1 196
l'abbe FR940104-2-00081 1 198
ka FR940104-2-00081 1 199
littorin FR940104-2-00081 1 201
lynge FR940104-2-00081 1 204
e. FR940104-2-00081 1 205
mathews FR940104-2-00081 1 207
jd FR940104-2-00081 1 208
neuberger FR940104-2-00081 1 210
osman FR940104-2-00081 1 213
pearce FR940104-2-00081 1 216
n. FR940104-2-00081 1 217
winkelman FR940104-2-00081 1 219
chlorophenoxy FR940104-2-00081 1 228
herbicides FR940104-2-00081 2 229 624
chlorophenois FR940104-2-00081 1 231
338:10271032 FR940104-2-00081 1 234
) FR940104-2-00081 6 235 303 350 486 642 674
some FR940104-2-00081 1 237
have FR940104-2-00081 2 240 659
shown FR940104-2-00081 1 241
slight FR940104-2-00081 1 243
elevated FR940104-2-00081 1 244
risk FR940104-2-00081 2 245 354
for FR940104-2-00081 3 246 411 605
farm FR940104-2-00081 1 250
forestry FR940104-2-00081 1 252
burmeister FR940104-2-00081 1 257
lf FR940104-2-00081 1 258
1981. FR940104-2-00081 1 260
iowa FR940104-2-00081 1 264
farmers FR940104-2-00081 3 265 315 359
: FR940104-2-00081 1 266
19711978. FR940104-2-00081 1 267
national FR940104-2-00081 1 271
institute FR940104-2-00081 1 273
66:461464 FR940104-2-00081 1 274
alavanja FR940104-2-00081 1 276
mc FR940104-2-00081 1 277
merkle FR940104-2-00081 1 279
teske FR940104-2-00081 1 282
eaton FR940104-2-00081 1 284
b. FR940104-2-00081 2 285 328
reed FR940104-2-00081 1 287
b FR940104-2-00081 1 288
1989. FR940104-2-00081 1 290
forest FR940104-2-00081 1 293
soil FR940104-2-00081 1 295
conservationists FR940104-2-00081 1 296
archives FR940104-2-00081 1 298
environmental FR940104-2-00081 3 300 549 593
44:94101 FR940104-2-00081 1 302
however FR940104-2-00081 2 305 647
only FR940104-2-00081 1 307
one FR940104-2-00081 1 308
study FR940104-2-00081 2 309 367
concerning FR940104-2-00081 1 310
small FR940104-2-00081 1 312
subt FR940104-2-00081 1 313
morrison FR940104-2-00081 2 317 366
savitz FR940104-2-00081 1 320
semenciw FR940104-2-00081 1 324
hulka FR940104-2-00081 1 327
mao FR940104-2-00081 1 330
y. FR940104-2-00081 1 331
morison FR940104-2-00081 1 333
wigle FR940104-2-00081 1 336
1993. FR940104-2-00081 1 338
farming FR940104-2-00081 1 339
american FR940104-2-00081 1 345
epidemiology FR940104-2-00081 1 348
137:270280 FR940104-2-00081 1 349
associated FR940104-2-00081 1 351
specifically FR940104-2-00081 1 360
so FR940104-2-00081 1 369
recent FR940104-2-00081 1 370
too FR940104-2-00081 1 374
early FR940104-2-00081 1 375
determine FR940104-2-00081 2 377 498
whether FR940104-2-00081 2 378 499
its FR940104-2-00081 1 379
results FR940104-2-00081 1 380
will FR940104-2-00081 1 381
replicated FR940104-2-00081 1 383
by FR940104-2-00081 2 384 544
other FR940104-2-00081 3 385 482 567
research FR940104-2-00081 1 386
accordingly FR940104-2-00081 1 388
secretary FR940104-2-00081 1 391
has FR940104-2-00081 2 392 418
found FR940104-2-00081 1 393
credible FR940104-2-00081 2 396 409
against FR940104-2-00081 1 398
outweighs FR940104-2-00081 1 407
such FR940104-2-00081 3 412 556 667
he FR940104-2-00081 1 417
determined FR940104-2-00081 2 419 580
positive FR940104-2-00081 1 422
does FR940104-2-00081 1 424
exist FR940104-2-00081 1 426
peripheral FR940104-2-00081 3 432 539 632
neuropathy FR940104-2-00081 3 433 540 633
hepatobiliary FR940104-2-00081 1 435
cancers FR940104-2-00081 4 436 439 443 446
bone FR940104-2-00081 1 438
female FR940104-2-00081 1 441
reproductive FR940104-2-00081 1 442
renal FR940104-2-00081 1 445
testicular FR940104-2-00081 1 448
leukemia FR940104-2-00081 1 451
abnormal FR940104-2-00081 1 453
sperm FR940104-2-00081 1 454
parameters FR940104-2-00081 1 455
infertility FR940104-2-00081 1 457
cognitive FR940104-2-00081 1 459
neuropsychiatric FR940104-2-00081 1 461
disorders FR940104-2-00081 6 462 470 474 477 480 550
motor/coordination FR940104-2-00081 1 464
dysfunction FR940104-2-00081 1 465
metabolic FR940104-2-00081 1 467
digestive FR940104-2-00081 1 469
immune FR940104-2-00081 1 472
system FR940104-2-00081 1 473
circulatory FR940104-2-00081 1 476
respiratory FR940104-2-00081 1 479
than FR940104-2-00081 1 483
lung FR940104-2-00081 1 484
nasal/nasopharyngeal FR940104-2-00081 1 489
inadequate/insufficient FR940104-2-00081 1 495
exists FR940104-2-00081 1 502
available FR940104-2-00081 1 511
insufficient FR940104-2-00081 1 515
quality FR940104-2-00081 1 516
consistency FR940104-2-00081 1 518
or FR940104-2-00081 2 520 530
statistical FR940104-2-00081 3 521 609 661
strength FR940104-2-00081 1 522
permit FR940104-2-00081 1 524
conclusion FR940104-2-00081 2 526 645
regarding FR940104-2-00081 1 527
presence FR940104-2-00081 1 529
absence FR940104-2-00081 1 531
can FR940104-2-00081 1 541
induced FR940104-2-00081 1 543
many FR940104-2-00081 1 545
medical FR940104-2-00081 1 547
unrelated FR940104-2-00081 1 551
aging FR940104-2-00081 1 558
alcoholism FR940104-2-00081 1 560
diabetes FR940104-2-00081 1 562
toxic FR940104-2-00081 1 568
chemicals FR940104-2-00081 1 569
last FR940104-2-00081 1 572
time FR940104-2-00081 2 573 619
va FR940104-2-00081 1 574
considered FR940104-2-00081 1 575
this FR940104-2-00081 1 576
issue FR940104-2-00081 1 577
after FR940104-2-00081 1 582
receiving FR940104-2-00081 1 583
advice FR940104-2-00081 1 585
veterans FR940104-2-00081 1 588
' FR940104-2-00081 1 589
advisory FR940104-2-00081 1 590
committee FR940104-2-00081 1 591
on FR940104-2-00081 2 592 651
hazards FR940104-2-00081 1 594
was FR940104-2-00081 1 598
sufficient FR940104-2-00081 1 599
meet FR940104-2-00081 1 602
requirements FR940104-2-00081 1 604
`` FR940104-2-00081 1 607
'' FR940104-2-00081 1 612
standard FR940104-2-00081 1 614
effect FR940104-2-00081 1 616
at FR940104-2-00081 1 617
containing FR940104-2-00081 1 625
subsequent FR940104-2-00081 1 629
development FR940104-2-00081 1 630
under FR940104-2-00081 1 634
certain FR940104-2-00081 1 635
circumstances FR940104-2-00081 1 636
see FR940104-2-00081 1 638
57 FR940104-2-00081 1 639
fr FR940104-2-00081 1 640
223638 FR940104-2-00081 1 641
relied FR940104-2-00081 1 649
heavily FR940104-2-00081 1 650
case FR940104-2-00081 1 652
reports FR940104-2-00081 1 653
anecdotal FR940104-2-00081 1 657
singer FR940104-2-00081 2 669 676
colleagues FR940104-2-00081 1 671
1982 FR940104-2-00081 1 673
moses FR940104-2-00081 1 679
valciukas FR940104-2-00081 1 682
lilis FR940104-2-00081 1 685
